NME2 Antibody (N-term) Blocking Peptide

Product Overview

• Article Name: NME2 Antibody (N-term) Blocking Peptide
• Biozol Catalog Number: ABT-BP8081A
• Supplier Catalog Number: BP8081a
• Alternative Catalog Number: ABT-BP8081A-500UG
• Manufacturer: Abcepta
• Category: Proteine/Peptide
• Alternative Names: Nucleoside diphosphate kinase B, NDK B, NDP kinase B, C-myc purine-binding transcription factor PUF, Histidine protein kinase NDKB, nm23-H2, NME2, NM23B

Product Description

NM23 is a heterodimeric protein functioning as a nucleoside diphosphate (NDP) kinase. NME1 and NME2 comprise the 152 amino acid A and B polypeptide chains of the NM23 enzyme, respectively. NME2 is identical to the beta subunit of human erythrocyte NDP kinase. NDP kinases are involved in the synthesis of nucleoside triphosphates, and NM23 may act in the regulation of signal transduction by complexing with G proteins, causing activation/inactivation of developmental pathways. NEM2 has been identified as a putative tumor suppressor. High expression of mouse NME2 is detected in heart, liver, and kidney, with moderate expression in skeletal muscle, and negligible expression in other mouse tissues examined.

Product Properties

• NCBI: 4831
• UniProt: P22392
• Form: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
• Target: The synthetic peptide sequence is selected from aa 40~54 of human NME2.